External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AACR 2024
Roche and Genentech at

AACR 2024

April 05 - April 10
California, USA / Virtual (Hybrid)
aacr.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:30 PM
Duration 29mins California
IMvoke010: A phase III, double-blind randomized trial of atezolizumab (atezo) after definitive local therapy vs placebo in patients (pts) with high-risk locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)
Deborah J. Wong, Jérôme Fayette, Maria Teixeira, Prabhash Kumar, Ricard Mesia, Andrzej Kawecki, Arunee Dechaphunkul, José Dinis, Ye Guo, Muneyuki Masuda, Ching-Yun Hsieh, Maria Grazia Ghi, Claudia Vaz de Melo Sette, Tao Jiang, Yibing Yan, Monika Kaul, Ritika Jagtiani, Christina Matheny, Vaikunth Cuchelkar, Robert Haddad
Oncology | Head and Neck Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:30 PM
Duration 149mins California, USA
Trastuzumab emtansine in patients (pts) with HER2 mutation-positive (HER2mut) tumors: TAPISTRY study
Kim J-E, Thomas D, Gadgeel S, Corassa M, Tran T, Girda E, Richards D, Tejpar S, Chen D, Fang J, Patel S, Wilson T, Barlesi F
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:00 PM
Duration 210mins California, USA
Tumor Microenvironment (TME) biomarkers of TIGIT and PD-L1 immune checkpoint blockade in Cervical Cancer: An Exploratory Biomarker Analysis from SKYSCRAPER-04 (SKY04) Study
Krishnan V, Chang CW, Bader E, Salani R, Monk BJ, Kim YM, Ghamande S, Hall SL, Lorusso D, Barraclough L, Gilbert L, Ramirez AG, Lu CH, Berton D, Colombo N, Castro M, Lin YG, McCormack M, Molinero L
Oncology | Cervical Cancer - Ovarian Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 210mins California, USA
IMpower010: updated results from Asian patients in a Phase III study of adjuvant atezolizumab vs best supportive care in resected stage IB-IIIA NSCLC
Wang J, Altorki N, Felip E, Wakelee H, Vallieres, E, Zhou C, Fang J, Min T, He J, Liu Y, Fan Y, Belleli R, McNally V, Bennett E, Gitlitz BJ
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 210mins California, USA
RNA-seq molecular subtypes and gene expression signatures in the phase 3 IMpower151 China study of 1L bevacizumab + pemetrexed/paclitaxel ± atezolizumab in metastatic NSCLC
Caicun Zhou, Charlie Sun, Stacey Huang, Xiaorong Dong, Gongyan Chen, Zhehai Wang, Xianghua Wu, Yu Yao, Yiping Zhang, Ying Cheng, Hongming Pan, Xiaodong Zhang, Jiuwei Cui, Lifeng Wang, Xi Chen, Xiaoling Li, Ziping Wang, Qiming Wang, Jianxing He, Mengzhao Wang, Grace Qian, Qiong Wu, Shanshan Li, Habib Hamidi, David S. Shames, Marcus Ballinger, Minu Srivastava
Oncology | Non-Small Cell Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 210mins California, USA
Phase Ib/II, open-label, randomized evaluation of atezolizumab and etrumadent in combination with chemotherapy in MORPHEUS-pancreatic ductal adenocarcinoma
KP Kim, J Lacy, D-Y Oh, M P Sarvisé, T Macarulla, A Alistar, E O’Reilly, J Lau, T Xu , F Young , H Prizant
Oncology | Pancreatic Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.